ATE164066T1 - Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol - Google Patents

Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol

Info

Publication number: ATE164066T1
Authority: AT; Austria
Prior art keywords: methylthiazole; hydroxyethyl; pharmaceutical formulations; chlorine; new pharmaceutical
Prior art date: 1990-08-15

Application number

AT91915138T

Other languages

English (en)

Inventor

Bernard Robin Boar

Alan John Cross

Alfred Richard Green

Curt-Eric Hagberg

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-15

Filing date

1991-08-07

Publication date

1998-04-15

1991-08-07 Application filed by Astra Ab filed Critical Astra Ab

1998-04-15 Application granted granted Critical

1998-04-15 Publication of ATE164066T1 publication Critical patent/ATE164066T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
OOKATFCTRGAPQX-UHFFFAOYSA-N 2-chloro-1-(4-methyl-1,3-thiazol-5-yl)ethanol Chemical compound CC=1N=CSC=1C(O)CCl OOKATFCTRGAPQX-UHFFFAOYSA-N 0.000 abstract 1
230000003287 optical effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

AT91915138T 1990-08-15 1991-08-07 Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol ATE164066T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9002659A SE9002659D0 (sv)	1990-08-15	1990-08-15	New pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
ATE164066T1 true ATE164066T1 (de)	1998-04-15

Family

ID=20380161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91915138T ATE164066T1 (de)	1990-08-15	1991-08-07	Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol

Country Status (26)

Country	Link
US (1)	US5385921A (de)
EP (1)	EP0619734B1 (de)
JP (1)	JP3094077B2 (de)
AT (1)	ATE164066T1 (de)
AU (1)	AU657490B2 (de)
BG (1)	BG97446A (de)
CA (1)	CA2088775A1 (de)
CZ (1)	CZ279586B6 (de)
DE (1)	DE69129126T2 (de)
DK (1)	DK0619734T3 (de)
ES (1)	ES2114891T3 (de)
FI (1)	FI930608L (de)
HU (1)	HUT65821A (de)
IE (1)	IE912818A1 (de)
IL (1)	IL99169A (de)
IS (1)	IS3743A7 (de)
LT (1)	LT3978B (de)
LV (1)	LV10921B (de)
NO (1)	NO303447B1 (de)
NZ (1)	NZ239329A (de)
PT (1)	PT98688B (de)
RO (1)	RO112994B1 (de)
RU (1)	RU2093155C1 (de)
SE (1)	SE9002659D0 (de)
SK (1)	SK8793A3 (de)
WO (1)	WO1992003134A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9901658D0 (sv) *	1999-05-06	1999-05-06	Astra Ab	New formulation
SE9904177D0 (sv) *	1999-11-18	1999-11-18	Astra Ab	Novel compounds
WO2002083863A2 (en)	2001-04-17	2002-10-24	Sepracor, Inc.	Thiazole and other heterocyclic ligands and use thereof
CN103772313B (zh) *	2014-01-02	2015-10-14	郑桂富	一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) *	2020-10-26	2021-01-26	宜宾学院	油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2825966A1 (de) *	1978-06-14	1980-01-03	Basf Ag	Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) *	1986-01-14	1986-02-19	Merck Sharp & Dohme	N-methyl-d-aspartate receptor antagonists

1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
1991
- 1991-08-07 EP EP91915138A patent/EP0619734B1/de not_active Expired - Lifetime
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 FI FI930608A patent/FI930608L/fi unknown
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en not_active Ceased
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0619734A1 (de)	1994-10-19
BG97446A (bg)	1994-03-24
PT98688A (pt)	1992-07-31
NO930452L (no)	1993-02-09
NO303447B1 (no)	1998-07-13
JP3094077B2 (ja)	2000-10-03
FI930608A7 (fi)	1993-02-11
IL99169A0 (en)	1992-07-15
IL99169A (en)	1995-10-31
CZ279586B6 (cs)	1995-05-17
RO112994B1 (ro)	1998-03-30
EP0619734B1 (de)	1998-03-18
AU8409291A (en)	1992-03-17
SK8793A3 (en)	1993-07-07
PT98688B (pt)	1999-01-29
NO930452D0 (no)	1993-02-09
LT3978B (en)	1996-06-25
IS3743A7 (is)	1992-02-16
LTIP1714A (en)	1995-09-25
DE69129126D1 (de)	1998-04-23
AU657490B2 (en)	1995-03-16
IE912818A1 (en)	1992-02-26
CA2088775A1 (en)	1992-02-16
CZ16693A3 (en)	1994-02-16
RU2093155C1 (ru)	1997-10-20
HUT65821A (en)	1994-07-28
NZ239329A (en)	1994-11-25
DE69129126T2 (de)	1998-07-23
DK0619734T3 (da)	1998-10-05
FI930608A0 (fi)	1993-02-11
US5385921A (en)	1995-01-31
LV10921B (en)	1996-08-20
SE9002659D0 (sv)	1990-08-15
JPH06500097A (ja)	1994-01-06
ES2114891T3 (es)	1998-06-16
FI930608L (fi)	1993-02-11
HU9300388D0 (en)	1993-04-28
WO1992003134A1 (en)	1992-03-05
LV10921A (lv)	1995-12-20

Legal Events

Date	Code	Title	Description
1998-12-15	UEP	Publication of translation of european patent specification
2002-05-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
FI913248A0 (fi)	1991-07-04	Kontrollerat frigoerande fast farmaceutisk doseringsform.
MX9102473A (es)	1992-06-01	Agentes farmaceuticos.
DK1155695T3 (da)	2010-04-06	Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
DE69227407D1 (de)	1998-12-03	Superlumineszierende optische Quelle
ITRM910696A0 (it)	1991-09-18	Composizioni farmaceutiche per l'applicazione per via nasale.
FI940192A7 (fi)	1994-01-14	2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisi na aineina
DK0535034T3 (da)	2002-12-09	Farmaceutisk aktive benzoquinazolinforbindelser
DK0532595T3 (da)	1997-04-07	Farmakologisk anvendelse af visse cystinderivater
FI911308A7 (fi)	1991-09-20	Lipopeptidijohdannaiset
ITMI910456A0 (it)	1991-02-21	Composizione farmaceutica per il trattamento della cataratta
DE69129126D1 (de)	1998-04-23	Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol
TR27833A (tr)	1995-08-31	Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
DE69115528D1 (de)	1996-02-01	Neue pharmazeutische Verwendungen von Forskolin-Derivaten
ATE138570T1 (de)	1996-06-15	Neue verwendung von bambuterol
RU93004984A (ru)	1995-05-10	Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
NO912979L (no)	1992-02-03	Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenederivater.
FI910773A0 (fi)	1991-02-18	Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex.
FI930987A7 (fi)	1993-04-07	Uudet prostaglandiini-I2-johdannaiset
SE9000288D0 (sv)	1990-01-26	New use
MX9203359A (es)	1992-09-01	Nuevas composiciones farmaceuticas de insulina.
KR920007598U (ko)	1992-05-19	의약용 캅셀
ITMI911049A1 (it)	1992-10-17	Composizione oftalmica
ES1016977Y (es)	1992-06-16	Jeringuilla no reutilizable.
GR1001368B (el)	1993-10-29	Φαρμακευτικοί φορείς.